New Delhi: GPT Healthcare Ltd shares listed with a premium of over 16 percent on Thursday against the issue price of Rs 186.

New Delhi: A recent study has revealed that despite free tuberculosis (TB) diagnosis and treatment under the National TB ...

Cambridge: AstraZeneca and Daiichi Sankyo have voluntarily withdrawn the marketing authorisation application (MAA) in the EU ...

Gestational diabetes early in pregnancy tied to risk of postpartum glucose intolerance finds a study published in the Journal ...

In the past, hip surgeries concentrated on fixing surgical issues and managing pain around the operation, paying little ...

A groundbreaking Swedish study found that oral contraceptives are associated with an increased risk of cardiovascular disease ...

A new study published in The Laryngoscope journal showed that possibilities for cochlear implantation (CI) are growing as ...

A research team co-led by a physician-scientist at the University of Arizona College of Medicine-Tucson’s Sarver Heart Center ...

An analysis of genetic sequencing data and gene and protein expression studies from patients with yellow nail syndrome (YNS) ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

China: A new randomized clinical trial has demonstrated that QX004N, a humanized anti–IL–23 monoclonal antibody, offers ...

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...